FEATURED RESOURCES How to Find Psychedelic Clinical Trials Near Me Are you interested in joining clinical trials involving psilocybin (magic mushrooms), LSD, MDMA, DMT, 5-MeO DMT, ketamine and other psychedelic compounds? Our search tool provides organized access to the information you’ll need to...
Recent Clinical Trials & Research on Creativity and Psychedelics The last five years have seen the most research activity around psychedelics since the 1960s, driven by early but promising evidence about their potential as a treatment for mental health conditions. A handful of these studies have con...
Earlier this week, the Food and Drug Administration issued a draft of proposed guidelines for clinical researchers conducting trials on psychedelic drugs. Even though the Drug Enforcement Administration categorizes psychedelic drugs as Schedule I (me... ...
Human trials with ketamine shed light on various processes contributing to plasticity. For instance, a cross-sectional study conducted by Fan and colleagues revealed that ketamine addiction can lead to low-grade inflammation (Fan et al.2015). Further, three other studies specifically focused on TRD ...
(e.g., the head-twitch response), only human clinical studies can ultimately confirm that it is non-hallucinogenic. Nevertheless, our work highlights the potential of using analogs of psychedelics to treat stress-related brain disorders. Furthermore, human clinical trials suggest that classical ...
roots will be erased." Unprompted, I hear a version of this concern from one Berkshires-area healer who, for legal reasons, prefers to remain unnamed; she tells me that, although she supports expanding access to psychedelics, she worries about the experience becoming pro forma and “clinical....
yeah. we bootstrapped this from the beginning in my clinical home, state of nevada, and then we just kept expanding based on where i work. and our story was very interesting because i was a doctor, derek was the integration guy, we bootstrapped and kept expanding, expanding, as derek ...
Psychedelics are a class of drugs unified by their ability to alter sensory perception and change the way we process information. Clinical trials incorporating these drugs, which have resurged after being shuttered in the 1970s, have demonstrated that psychedelic-assisted therapy is remarkably good at...
In addition, the promising neurotrophic and anti-inflammatory properties of psilocybin are generating interest as a therapeutic hypothesis for neurodegenerative diseases, although preclinical results are consistent, clinical trials are nowadays limited and mostly relate to the treatment of depression associated...
Meanwhile, FDA approval of MDMA for post traumatic stress disorder (PTSD) could arrive by 2021. In 2018, psilocybin got Breakthrough Therapy designation from the FDA, and the clinical trials for psilocybin depression treatment are in phase two of three. As we stand on the precipice of ps...